1
|
Benn JS, Nunez CM, Blue-McLendon A, Chaki SP, Ficht TA, Rice-Ficht AC, Cook WE. LETHAL TOXIN NEUTRALIZING ANTIBODY RESPONSE INDUCED FOLLOWING ORAL VACCINATION WITH A MICROENCAPSULATED BACILLUS ANTHRACIS STERNE STRAIN 34F2 VACCINE PROOF-OF-CONCEPT STUDY IN WHITE-TAILED DEER ( ODOCOILEUS VIRGINIANUS). J Zoo Wildl Med 2024; 55:212-218. [PMID: 38453505 DOI: 10.1638/2023-0065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/25/2023] [Indexed: 03/09/2024] Open
Abstract
Improved methods are needed to prevent wildlife deaths from anthrax. Caused by Bacillus anthracis, naturally occurring outbreaks of anthrax are frequent but unpredictable. The commercially available veterinary vaccine is labeled for subcutaneous injection and is impractical for large-scale wildlife vaccination programs; therefore, oral vaccination is the most realistic method to control and prevent these outbreaks. We reported the induction of an anthrax-specific lethal toxin (LeTx) neutralizing antibody response in mice following oral vaccination with alginate microcapsules containing B. anthracis Sterne strain 34F2 spores, coated with poly-L-lysine (PLL) and vitelline protein B (VpB). We continued evaluating our novel vaccine formulation through this proof-of-concept study in white-tailed deer (WTD; Odocoileus virginianus; n = 9). We orally vaccinated WTD via needle-free syringe with three formulations of the encapsulated vaccine: 1) PLL-VpB-coated microcapsules with 107-8 spores/ml (n = 5), 2) PLL-VpB-coated microcapsules with 109-10 spores/ml (n = 2), and 3) PLL-coated microcapsules with 109-10 spores/ml (n = 2). Although the limited sample sizes require continued experimentation, we observed an anthrax-specific antibody response in WTD serum following oral vaccination with PLL-coated microcapsules containing 109 spores/ ml. Furthermore, this antibody response neutralized anthrax LeTx in vitro, suggesting that continued development of this vaccine may allow for realistic wildlife anthrax vaccination programs.
Collapse
Affiliation(s)
- Jamie S Benn
- Cook Wildlife Lab, Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA,
| | - Chase M Nunez
- Cook Wildlife Lab, Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA,
| | - Alice Blue-McLendon
- The Winnie Carter Wildlife Center, Department of Veterinary Pharmacology and Physiology, Texas A&M University, College Station, TX 77843, USA
| | - Sankar P Chaki
- The Global Health Research Complex, Division of Research, Texas A&M University, College Station, TX 77843, USA
| | - Thomas A Ficht
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX 77843, USA
| | - Allison C Rice-Ficht
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX 77843, USA
- Department of Molecular and Cellular Medicine, Texas A&M Health Science Center, College Station, TX 77843, USA
| | - Walter E Cook
- Cook Wildlife Lab, Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA
| |
Collapse
|
2
|
Nunez CM, Benn JS, Blue-McLendon A, Chaki SP, Ficht TA, Rice-Ficht AC, Cook WE. In Vitro Protection and Titer Duration of Anthrax-Specific Antibodies Following Subcutaneous Vaccination of White-tailed Deer (Odocoileus virginianus) with Bacillus anthracis Sterne 34F2 Strain Spores. J Wildl Dis 2024; 60:179-183. [PMID: 37921658 DOI: 10.7589/jwd-d-23-00019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2023] [Accepted: 09/20/2023] [Indexed: 11/04/2023]
Abstract
Outbreaks of anthrax, caused by the soilborne bacterium Bacillus anthracis, are a continuous threat to free-ranging livestock and wildlife in enzootic regions of the United States, sometimes causing mass mortalities. Injectable anthrax vaccines are commercially available for use in livestock, and although hand injection is not a cost- or time-effective long-term management plan for prevention in wildlife, it may provide a tool for managers to target selectively animals of high conservation or economic value. Vaccine-induced anthrax-specific antibody responses have been reported previously in white-tailed deer (Odocoileus virginianus), but the protective nature was not determined. In this study, five white-tailed deer were subcutaneously vaccinated with one dose (1 mL) of the Anthrax Spore Vaccine. Eight blood collections by jugular venipuncture were conducted over 146 d to measure the anthrax-specific antibody response in each deer's serum over time. Antibodies were first detected by ELISA and later with toxin neutralization assays to estimate in vitro protection. Average peak absorbance by ELISA occurred at 14 d postvaccination, whereas average peak in vitro protection occurred at 28 d postvaccination. Observed in vitro protection on average for white-tailed deer after this single-dose vaccination protocol lasted 42-56 d postvaccination, although three individuals still maintained lethal toxin-neutralizing serum antibody titers out to 112 d postvaccination. Vaccination responses were variable but effective to some degree in all white-tailed deer.
Collapse
Affiliation(s)
- Chase M Nunez
- Cook Wildlife Lab, Department of Veterinary Pathobiology, Texas A&M University, College of Veterinary Medicine and Biomedical Sciences, College Station, Texas 77843, USA
- These authors contributed equally to the work
| | - Jamie S Benn
- Cook Wildlife Lab, Department of Veterinary Pathobiology, Texas A&M University, College of Veterinary Medicine and Biomedical Sciences, College Station, Texas 77843, USA
- Current address: Caesar Kleberg Wildlife Research Institute, Texas A&M University-Kingsville, 700 University Blvd., MSC 218, Kingsville, Texas 78363, USA
- These authors contributed equally to the work
| | - Alice Blue-McLendon
- Winnie Carter Wildlife Center, Department of Veterinary Pharmacology and Physiology, Texas A&M University, College Station, Texas 77843, USA
| | - Sankar P Chaki
- Global Health Research Complex, Division of Research, Texas A&M University, College Station, Texas 77843, USA
| | - Thomas A Ficht
- Ficht Encapsulation Lab, Department of Veterinary Pathobiology, Texas A&M University, College Station, Texas 77843, USA
| | - Allison C Rice-Ficht
- Ficht Encapsulation Lab, Department of Veterinary Pathobiology, Texas A&M University, College Station, Texas 77843, USA
- Department of Molecular and Cellular Medicine, Texas A&M Health Science Center, College Station, Texas 77843, USA
| | - Walter E Cook
- Cook Wildlife Lab, Department of Veterinary Pathobiology, Texas A&M University, College of Veterinary Medicine and Biomedical Sciences, College Station, Texas 77843, USA
| |
Collapse
|
3
|
Hamer SA, Nunez C, Roundy CM, Tang W, Thomas L, Richison J, Benn JS, Auckland LD, Hensley T, Cook WE, Pauvolid-Corrêa A, Hamer GL. Persistence of SARS-CoV-2 neutralizing antibodies longer than 13 months in naturally-infected, captive white-tailed deer ( Odocoileus virginianus), Texas. Emerg Microbes Infect 2022; 11:2112-2115. [PMID: 35950943 PMCID: PMC9448430 DOI: 10.1080/22221751.2022.2112913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
After identifying a captive herd of white-tailed deer in central Texas with >94% seroprevalence with SARS-CoV-2 neutralizing antibodies in September 2021, we worked retrospectively through archived serum samples of 21 deer and detected seroconversion of all animals between December 2020 and January 2021. We then collected prospective samples to conclude that the duration of persistence of neutralizing antibodies is at least 13 months for 19 (90.5%) of the animals, with two animals converting to seronegative after six and eight months. Antibody titres generally waned over this time frame, but three deer had a temporary 4- to 8-fold increases in plaque reduction neutralization test titres over a month after seroconversion; anamnestic response cannot be ruled out.
Collapse
Affiliation(s)
- Sarah A Hamer
- Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA
| | - Chase Nunez
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, USA
| | | | - Wendy Tang
- Department of Entomology, Texas A&M University, College Station, TX, USA
| | - Logan Thomas
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, USA
| | - Jack Richison
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, USA
| | - Jamie S Benn
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, USA
| | - Lisa D Auckland
- Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA
| | - Terry Hensley
- Texas A&M Veterinary Medical Diagnostic Laboratory, College Station, TX, USA
| | - Walter E Cook
- Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, USA
| | - Alex Pauvolid-Corrêa
- Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA
| | - Gabriel L Hamer
- Department of Entomology, Texas A&M University, College Station, TX, USA
| |
Collapse
|
4
|
Benn JS, Chaki SP, Xu Y, Ficht TA, Rice-Ficht AC, Cook WE. Author Correction: Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores. NPJ Vaccines 2021; 6:109. [PMID: 34417464 PMCID: PMC8379169 DOI: 10.1038/s41541-021-00374-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Affiliation(s)
- Jamie S Benn
- Texas A&M University, Department of Veterinary Pathobiology, College Station, TX, 77843, USA.
| | - Sankar P Chaki
- Texas A&M University, Department of Veterinary Pathobiology, College Station, TX, 77843, USA
| | - Yi Xu
- Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, 77030, USA
| | - Thomas A Ficht
- Texas A&M University, Department of Veterinary Pathobiology, College Station, TX, 77843, USA
| | - Allison C Rice-Ficht
- Texas A&M University, Department of Veterinary Pathobiology, College Station, TX, 77843, USA.,Texas A&M Health Science Center, Department of Molecular and Cellular Medicine, College Station, TX, 77843, USA
| | - Walter E Cook
- Texas A&M University, Department of Veterinary Pathobiology, College Station, TX, 77843, USA
| |
Collapse
|
5
|
Benn JS, Chaki SP, Xu Y, Ficht TA, Rice-Ficht AC, Cook WE. Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores. NPJ Vaccines 2020; 5:59. [PMID: 32685200 PMCID: PMC7351773 DOI: 10.1038/s41541-020-0208-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2020] [Accepted: 06/05/2020] [Indexed: 11/30/2022] Open
Abstract
An oral vaccine against anthrax (Bacillus anthracis) is urgently needed to prevent annual anthrax outbreaks that are causing catastrophic losses in free-ranging livestock and wildlife worldwide. The Sterne vaccine, the current injectable livestock vaccine, is a suspension of live attenuated B. anthracis Sterne strain 34F2 spores (Sterne spores) in saponin. It is not effective when administered orally and individual subcutaneous injections are not a practical method of vaccination for wildlife. In this study, we report the development of a microencapsulated oral vaccine against anthrax. Evaluating Sterne spore stability at varying pH's in vitro revealed that spore exposure to pH 2 results in spore death, confirming that protection from the gastric environment is of main concern when producing an oral vaccine. Therefore, Sterne spores were encapsulated in alginate and coated with a protein shell containing poly-L-lysine (PLL) and vitelline protein B (VpB), a non-immunogenic, proteolysis resistant protein isolated from Fasciola hepatica. Capsule exposure to pH 2 demonstrated enhanced acid gel character suggesting that alginate microcapsules provided the necessary protection for spores to survive the gastric environment. Post vaccination IgG levels in BALBc/J mouse serum samples indicated that encapsulated spores induced anti-anthrax specific responses in both the subcutaneous and the oral vaccination groups. Furthermore, the antibody responses from both vaccination routes were protective against anthrax lethal toxin in vitro, suggesting that further optimization of this vaccine formulation may result in a reliable oral vaccine that will conveniently and effectively prevent anthrax in wildlife populations.
Collapse
Affiliation(s)
- Jamie S. Benn
- Texas A&M University, Department of Veterinary Pathobiology, College Station, TX 77843 USA
| | - Sankar P. Chaki
- Texas A&M University, Department of Veterinary Pathobiology, College Station, TX 77843 USA
| | - Yi Xu
- Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX 77030 USA
| | - Thomas A. Ficht
- Texas A&M University, Department of Veterinary Pathobiology, College Station, TX 77843 USA
| | - Allison C. Rice-Ficht
- Texas A&M University, Department of Veterinary Pathobiology, College Station, TX 77843 USA
- Texas A&M Health Science Center, Department of Molecular and Cellular Medicine, College Station, TX 77843 USA
| | - Walter E. Cook
- Texas A&M University, Department of Veterinary Pathobiology, College Station, TX 77843 USA
| |
Collapse
|
6
|
Edmunds DR, Albeke SE, Grogan RG, Lindzey FG, Legg DE, Cook WE, Schumaker BA, Kreeger TJ, Cornish TE. Chronic wasting disease influences activity and behavior in white‐tailed deer. J Wildl Manage 2018. [DOI: 10.1002/jwmg.21341] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- David R. Edmunds
- Department of Veterinary SciencesUniversity of Wyoming, Wyoming State Veterinary Laboratory1174 Snowy Range RoadLaramieWY82070USA
| | - Shannon E. Albeke
- Wyoming Geographic Information Science CenterUniversity of WyomingDepartment 4008, 1000 E. University AvenueLaramieWY82071USA
| | - Ronald G. Grogan
- Department of Veterinary SciencesUniversity of Wyoming, Wyoming State Veterinary Laboratory1174 Snowy Range RoadLaramieWY82070USA
| | - Frederick G. Lindzey
- Wyoming Cooperative Fish and Wildlife Research UnitUniversity of Wyoming, Department 3166, 1000 E. University Avenue, University of WyomingLaramieWY80271USA
| | - David E. Legg
- Department of Ecosystem Science and ManagementUniversity of Wyoming, Department 33541000 E. University AvenueLaramieWY82071USA
| | - Walter E. Cook
- Department of Veterinary PathobiologyCollege of Veterinary Medicine and Biomedical SciencesTexas A&M University, 4467 TAMUCollege StationTX77843USA
| | - Brant A. Schumaker
- Department of Veterinary SciencesUniversity of Wyoming, Wyoming State Veterinary Laboratory1174 Snowy Range RoadLaramieWY82070USA
| | - Terry J. Kreeger
- Wyoming Game and Fish Department2362 Highway 34WheatlandWY82201USA
| | - Todd E. Cornish
- Department of Veterinary SciencesUniversity of Wyoming, Wyoming State Veterinary Laboratory1174 Snowy Range RoadLaramieWY82070USA
| |
Collapse
|
7
|
Speiser KL, Schumaker BA, Cook WE, Cornish TE, Cammack KM, Miller MM. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17. J Am Vet Med Assoc 2016; 248:1043-9. [DOI: 10.2460/javma.248.9.1043] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
8
|
Cook WE, Jessup DA. Common ground for feral cats. J Am Vet Med Assoc 2015; 247:141-142. [PMID: 26349097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
|
9
|
Cook WE, Raisbeck MF, Cornish TE, Williams ES, Brown B, Hiatt G, Kreeger TJ. Paresis and death in elk (Cervus elaphus) due to lichen intoxication in Wyoming. J Wildl Dis 2007; 43:498-503. [PMID: 17699088 DOI: 10.7589/0090-3558-43.3.498] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
During February-April 2004, an estimated 400-500 free-ranging elk (Cervus elaphus) developed paresis, became recumbent, and died or were euthanized in the Red Rim Wildlife Habitat Management Area (RRWHMA), Wyoming, USA. Elk were found in sternal recumbency, alert and responsive, but unable to rise. Their condition progressed to lateral recumbency followed by dehydration, obtundation, and death. Gross lesions were limited to degenerative myopathy, with pallor and streaking in skeletal muscles. Microscopically, affected muscles had degenerative lesions of varying duration, severity, and distribution, some with early mineralization and attempts at regeneration. Diagnostic testing ruled out common infectious, inflammatory, toxic, and traumatic causes. Tumbleweed shield lichen (Xanthoparmelia chlorochroa) was found in the area and in the rumen of several elk. This lichen was collected and fed to three captive elk. Two of these elk exhibited signs of ataxia, which rapidly progressed to weakness and recumbency after 7 and 10 days on this diet, respectively, and a degenerative myopathy, consistent with lesions observed in the elk affected at RRWHMA, was observed. All remaining elk migrated from the RRWHMA during the spring and no subsequent losses have been documented.
Collapse
Affiliation(s)
- Walter E Cook
- Wyoming Game and Fish Department, 1174 Snowy Range Road, Laramie, Wyoming 82070, USA.
| | | | | | | | | | | | | |
Collapse
|
10
|
Naugle DE, Aldridge CL, Walker BL, Cornish TE, Moynahan BJ, Holloran MJ, Brown K, Johnson GD, Schmidtmann ET, Mayer RT, Kato CY, Matchett MR, Christiansen TJ, Cook WE, Creekmore T, Falise RD, Thomas Rinkes E, Boyce MS. West Nile virus: pending crisis for greater sage-grouse. Ecol Lett 2004. [DOI: 10.1111/j.1461-0248.2004.00631.x] [Citation(s) in RCA: 84] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
11
|
Abstract
Nine (four female, five male) captive adult Rocky Mountain bighorn sheep (Ovis canadensis) contracted brucellosis caused by Brucella abortus biovar 4 as a result of natural exposure to an aborted elk (Cervus elaphus) fetus. Clinical signs of infection were orchitis and epididymitis in males and lymphadenitis and placentitis with abortion in females. Gross pathologic findings included enlargement of the testes or epididymides, or both, and yellow caseous abscesses and pyogranulomas of the same. Brucella abortus biovar 4 was cultured in all bighorn sheep from a variety of tissues, including testes/epididymides, mammary gland, and lymph nodes. All bighorn sheep tested were positive on a variety of standard Brucella serologic tests. This is the first report of brucellosis caused by B. abortus in Rocky Mountain bighorn sheep. It also provides evidence that bighorn sheep develop many of the manifestations ascribed to this disease and that infection can occur from natural exposure to an aborted fetus from another species. Wildlife managers responsible for bighorn sheep populations sympatric with Brucella-infected elk or bison (Bison bison) should be cognizant of the possibility of this disease in bighorn sheep.
Collapse
Affiliation(s)
- Terry J Kreeger
- Wyoming Game and Fish Department, Wheatland, Wyoming 82201, USA.
| | | | | | | |
Collapse
|
12
|
Van Houten CK, Lee Belden E, Kreeger TJ, Williams ES, Edwards WH, Thorne ET, Cook WE, Mills KW. Validation of a Brucella abortus competitive enzyme-linked immunosorbent assay for use in Rocky Mountain elk (Cervus elaphus nelsoni). J Wildl Dis 2003; 39:316-22. [PMID: 12910758 DOI: 10.7589/0090-3558-39.2.316] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Brucellosis caused by infection with Brucella abortus is present in some elk (Cervus elaphus nelsoni) of the Greater Yellowstone Area (parts of Wyoming, Montana, and Idaho, USA). Since 1985, the Wyoming Game and Fish Department has vaccinated elk on elk feedgrounds in northwestern Wyoming during the winter months using B. abortus strain 19 (strain 19). Analysis of this vaccination program is hampered by the inability of standard serologic tests to differentiate between strain 19 vaccinated elk and those exposed to field strain B. abortus. In 1993, a competitive enzyme-linked immunosorbent assay (cELISA) was licensed to serologically differentiate between strain 19 vaccinated cattle and cattle exposed to field strain B. abortus. Seven groups of elk sera representing various B. abortus exposure histories were used to validate the cELISA test for elk. The cELISA test differentiated strain 19 vaccinated elk from elk that were challenged with B. abortus strain 2308, a pathogenic laboratory strain. The specificity of the cELISA was 96.8% for elk vaccinated with strain 19 only and sampled between 6 mo and 2 yr post vaccination, or with no B. abortus exposure. The sensitivity of the cELISA was 100%. The cELISA test will be useful in evaluating sera collected from elk in vaccinated, brucellosis endemic herds in the Greater Yellowstone Area.
Collapse
Affiliation(s)
- Clayton K Van Houten
- Department of Veterinary Sciences, University of Wyoming, Laramie, Wyoming 82071, USA.
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Abstract
Brucellosis is endemic in free-ranging elk (Cervus elaphus) and bison (Bison bison) in the Greater Yellowstone Area (GYA; USA). It is possible that an oral brucellosis vaccine could be developed and disseminated in the GYA to reduce disease transmission. Should this occur, non-target species other than elk and bison may come in contact with the vaccine resulting in morbidity or mortality. To assess biosafety, bighorn sheep (Ovis canadensis; n = 10), pronghorn (Antilocapra americana; n = 9), mule deer (Odocoileus hemionus; n = 11), moose (Alces alces shirasi; n = 10), and coyotes (Canis latrans; n = 24) were given a single oral dose of at least 1.0 x 10(10) colony-forming units of Brucella abortus strain RB51 vaccine (RB51). Animals were randomly divided into vaccinated and control groups. Ungulates were captured, blood sampled, and swabs taken from the nares, rectum, and vagina for bacterial culture on day 0, 42, and 84 post-inoculation (PI). On day 42, the vaccinated group became a control group and vice versa in a crossover design. Blood and swab samples were taken from coyotes on days 0, 14, 28, and 42 PI. There was no crossover for the coyote study. Two coyotes from each group were also euthanized and cultured for RB51 on days 42, 84, 168, and 336 PI. Blood samples were analyzed for hematologic changes and antibodies to RB51 using a modified dot-blot assay. No morbidity or mortality as a result of vaccination was observed in any animal. There were no differences in hematologic parameters at any time for ungulate species; vaccinated coyotes had higher hematocrit, hemoglobin, and eosinophil counts (P < or = 0.006). All individuals, except some moose, seroconverted to RB51. Strain RB51 was cultured from oropharyngeal lymph nodes from one coyote 42 days PI and from a moose 117 days PI. This study suggested that a single oral dose of RB51 was safe in these species.
Collapse
Affiliation(s)
- Terry J Kreeger
- Wyoming Game and Fish Department, 2362 Highway 34, Wheatland, Wyoming 82201, USA.
| | | | | | | | | |
Collapse
|
14
|
Abstract
Brucella abortus strain RB51 is used as a vaccine because it induces antibodies that do not react on standard serologic tests for brucellosis allowing differentiation between vaccination and infection. Strain RB51 was evaluated in captive elk (Cervus elaphus) to determine if vaccination protected against abortion following experimental challenge. Thirty elk were vaccinated intramuscularly with 1.0 x 10(10) colony-forming units (CFU) of strain RB51 in March 1998. Fourteen of these were given a booster dose of 1.13 x 10(10) CFU exactly 1 yr later. All vaccinated elk seroconverted via a modified dot blot assay to strain RB51 with the booster group having higher titers (P < or = 0.001). Seventeen other elk served as unvaccinated controls. All elk were bred and determined pregnant using pregnancy-specific protein B analysis. Elk were challenged in March 2000 with 1.1 x 10(7) CFU of B. abortus strain 2308 administered intraconjunctivally and all elk seroconverted to strain 2308. Fifteen of 17 control elk aborted; 16 of 16 elk given a single vaccination aborted (P = 0.44); and 13 of 14 elk given a booster aborted (P = 0.86). There were two viable calves in the control group and one in the booster group. Strain 2308 was recovered from fetuses and nonviable calves in all groups. Based on the results of this and other studies, the use of strain RB51 to prevent abortion in elk cannot be recommended.
Collapse
Affiliation(s)
- Terry J Kreeger
- Wyoming Game and Fish Department, 2362 Highway 34, Wheatland, Wyoming 82201, USA.
| | | | | | | | | |
Collapse
|
15
|
Cook WE, Williams ES, Thorne ET, Kreeger TJ, Stout G, Bardsley K, Edwards H, Schurig G, Colby LA, Enright F, Elzer PH. Brucella abortus strain RB51 vaccination in elk. I. Efficacy of reduced dosage. J Wildl Dis 2002; 38:18-26. [PMID: 11838212 DOI: 10.7589/0090-3558-38.1.18] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Bovine brucellosis is a serious zoonotic disease affecting some populations of Rocky Mountain elk (Cervus elaphus nelsoni) and bison (Bison bison) in the Greater Yellowstone Area, USA. The fear that elk and/or bison may spread Brucella abortus to livestock has prompted efforts to reduce or eliminate the disease in wildlife. Brucella abortus strain RB51 (RB51) vaccine has recently been approved for use in cattle. Unlike strain 19 vaccine, RB51 does not cause false positive reactions on standard brucellosis serologic tests. If effective, it may become the vaccine of choice for wildlife. In February 1995, 45 serologically negative female elk calves were trapped and taken to the Sybille Wildlife Research and Conservation Education Unit near Wheatland, Wyoming, USA. In May 1995, 16 of these elk calves were hand-vaccinated with 1 x 10(9) colony forming units (CFU) of RB51, 16 were vaccinated with 1 x 10(8) CFU RB51 by biobullet, and 13 were given a saline placebo. The elk were bred in fall of 1996 and they were challenged with 1 x 10(7) CFU of B. abortus strain 2308 by intraconjunctival inoculation in March 1997. Thirteen (100%) control elk aborted, 14 (88%) hand-vaccinated elk aborted, and 12 (75%) biobullet vaccinated elk aborted or produced nonviable calves. These results suggest that a single dose of 1 x 10(8) to 1 x 10(9) CFU RB51 does not provide significant protection against B. abortus induced abortion in elk. However, the vaccine appears to be safe at this dose and additional study may reveal a more effective RB51 vaccine regimen for elk.
Collapse
Affiliation(s)
- Walter E Cook
- Department of Veterinary Science, University of Wyoming, 1174 Snowy Range Road, Laramie, Wyoming 82070, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Abstract
Brucella abortus strain RB51 is an approved brucellosis vaccine for use in cattle that may have potential as an oral vaccine for use in elk (Cervus elaphus) and/or bison (Bison bison). This study was designed to determine effects of strain RB51 on deer mice (Peromyscus maniculatus), a nontarget species that could have access to treated baits in a field situation. In February 1994, 90 mice were orally dosed or intraperitoneally injected with 1 x 10(8) colony forming units strain RB51 and 77 controls were similarly dosed with sterile saline. At weekly intervals through early April 1994, 4 to 6 mice from each group were euthanized, gross necropsies performed, spleens and uteruses cultured, and tissues examined histologically. All orally inoculated mice cleared the infection by 6 wk post-inoculation (PI). While most of the injected mice cleared the infection by 7 wk PI, a few required 9 wk. There were minimal adverse effects attributable to strain RB51. Apparently, strain RB51 would not negatively impact P. maniculatus populations if it were used in a field situation. Also, deer mice appear to be able to clear the vaccine in 6 to 9 wk, thus the probability of these mice transmitting the vaccine to other animals is low.
Collapse
Affiliation(s)
- W E Cook
- School of Veterinary Medicine, University of California, Davis 95617, USA.
| | | | | | | | | |
Collapse
|
17
|
|
18
|
Abstract
Some of the elk (Cervus elaphus nelsoni) of the Greater Yellowstone Area (Wyoming, Idaho, Montana; USA) are infected with Brucella abortus, the bacterium that causes bovine brucellosis. Brucella abortus strain RB51 vaccine is being considered as a means to control B. abortus induced abortions in cow elk. However, the most probable vaccination strategies for use in free-ranging elk might also result in some bull elk being inoculated, thus, it is important to insure that the vaccine is safe in these animals. In the winter of 1995, 10 free-ranging bull elk calves were captured, tested for B. abortus antibodies, and intramuscularly inoculated with 1.0 x 10(9) colony forming units (CFU) of B. abortus strain RB51. Blood was collected for hemoculture and serology every 2 wk after inoculation for 14 wk. Beginning 4 mo postinoculation and continuing until 10 mo postinoculation elk were serially euthanized, necropsied, and tissues collected for culture and histopathology. These elk cleared the organism from the blood within 6 wk and from all tissues within 10 mo. No lesions attributable to B. abortus were found grossly and only minimal to mild lymphoplasmacytic epididymitis was found in a few elk on histologic examination. In a separate study, six adult bull elk from Wind Cave National Park (South Dakota, USA) were taken to a ranch near Carrington (North Dakota, USA). Three were orally inoculated with approximately 1.0 x 10(10) CFU of RB51 and three were inoculated with corn syrup and saline. Ninety days post-inoculation semen was examined and cultured from these bulls. Strain RB51 was not cultured from their semen at that time. There were no palpable abnormalities in the genital tract and all elk produced viable sperm. Although they contain small sample sizes, these studies suggest that B. abortus strain RB51 is safe in bull elk.
Collapse
Affiliation(s)
- W E Cook
- Department of Veterinary Science, University of Wyoming, Laramie 82070, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Abstract
To determine if Mycobacterium avium paratuberculosis has persisted in tule elk (Cervus elaphus nannodes) at Point Reyes National Seashore (California, USA), 100 fresh fecal samples were collected. Feces were cultured on a modified BACTEC 12B radiometric medium for detection of M. avium paratuberculosis. Four samples, coming from two separate groups of elk tested positive for M. avium paratuberculosis. Thus, a noninvasive technique was used to document the continued presence of M. avium paratuberculosis in elk at Point Reyes National Seashore. These findings document persistence of this organism for a period of at least 13 yr in a free ranging herd of elk, with a 6 yr absence of observed clinical signs.
Collapse
Affiliation(s)
- W E Cook
- Department of Veterinary Science, University of Wyoming, Laramie 82070, USA
| | | | | | | | | |
Collapse
|
20
|
|
21
|
Cook WE. Acute hepatic failure in the horse. Vet Rec 1969; 85:421-2. [PMID: 5390519 DOI: 10.1136/vr.85.15.421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|